Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance Oragenics Q2 2023 Earnings Narrowing Loss Surprises No Revenue Yet AGM Q1 2026 Earnings Strong EPS Beat Driven by Core Operations SHIM Q1 2026 Earnings WiderthanExpected Loss Drags Shares Lower